Synthesis of 86 species of 1,5-diaryl-3-oxo-1,4-pentadienes analogs of curcumin can yield a good lead in vivo
Open Access
- 28 May 2011
- journal article
- Published by Springer Nature in BMC Pharmacology
- Vol. 11 (1) , 4
Abstract
Background: Curcumin is known to possess many anti-tumor properties such as inhibition of tumor growth and induction of apotosis. However, limited bioavailability of curcumin prevents its clinical application. A synthesized curcumin analog, 1,5-diaryl-3-oxo-1,4-pentadiene such as GO-Y030, has the improved anti-tumor potentialin vitroas well as in mouse model of colorectal carcinogenesis.Results: These compounds were divided into two groups; one is the higher anti-proliferative group, in which 79.7% of 1,5-diaryl-3-oxo-1,4-pentadienes were clustered. One of the 1,5-diaryl-3-oxo-1,4-pentadiene analogs, GO-Y078 has the most enhanced growth inhibition, and its solubility was improved, compared with curcumin. GO-Y078 inhibits NF-κB transactivation, as well as expression of TP53 and DR5 more effectively than curcumin. In a mouse model, GO-Y078 presented 1.4 fold more survival elongation that was not achieved by curcumin and GO-Y030.Conclusions: The 1,5-diaryl-3-oxo-1,4-pentadiene analogs can yield good lead compounds for cancer chemotherapy, to overcome low bioavailability of curcumin.Keywords
This publication has 29 references indexed in Scilit:
- Structure–activity relationship of C5-curcuminoids and synthesis of their molecular probes thereofBioorganic & Medicinal Chemistry, 2010
- Natural derivatives of curcumin attenuate the Wnt/β-catenin pathway through down-regulation of the transcriptional coactivator p300Biochemical and Biophysical Research Communications, 2008
- Rottlerin induces apoptosis via death receptor 5 (DR5) upregulation through CHOP-dependent and PKC -independent mechanism in human malignant tumor cellsCarcinogenesis, 2008
- Anticancer and carcinogenic properties of curcumin: Considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agentMolecular Nutrition & Food Research, 2008
- Synthesis and biological analysis of new curcumin analogues bearing an enhanced potential for the medicinal treatment of cancerMolecular Cancer Therapeutics, 2006
- Curcumin Inhibits Platelet-Derived Growth Factor–Stimulated Vascular Smooth Muscle Cell Function and Injury-Induced Neointima FormationArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Lack of Correlation between p53-Dependent Transcriptional Activity and the Ability to Induce Apoptosis among 179 Mutant p53sCancer Research, 2005
- Synthetic curcumin analogs inhibit activator protein-1 transcription and tumor-induced angiogenesisBiochemical and Biophysical Research Communications, 2004
- Inhibitory effects of curcumin and capsaicin on phorbol ester‐induced activation of eukaryotic transcription factors, NF‐κB and AP‐1BioFactors, 2000
- Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane)Journal of Biological Chemistry, 1995